Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Mar;14(2):500-501.
doi: 10.1177/1932296819888213. Epub 2019 Dec 17.

Lipohypertrophy Effect on Glycemic Profile in an Adult With Type 1 Diabetes Using Scanned Continuous Glucose Monitoring

Affiliations
Case Reports

Lipohypertrophy Effect on Glycemic Profile in an Adult With Type 1 Diabetes Using Scanned Continuous Glucose Monitoring

Philippe Oriot et al. J Diabetes Sci Technol. 2020 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: PO and MPH wrote the manuscript and researched data, contributed to discussion and reviewed/edited the manuscript. PO is the guarantor of this case report and, as such, takes responsibility for the integrity of the data and the accuracy of the data analysis.

Similar articles

Cited by

  • Incidental findings of clinical relevance.
    Trabauer BM, Szag K, Krampla W. Trabauer BM, et al. Wien Klin Wochenschr. 2021 May;133(9-10):509-510. doi: 10.1007/s00508-020-01788-6. Epub 2020 Dec 22. Wien Klin Wochenschr. 2021. PMID: 33351154 No abstract available.

References

    1. McGill JB, Ahmann A. Continuous glucose monitoring with multiple daily insulin treatment: outcome studies. Diabetes Technol Ther. 2017;19(S3):S3-S12. - PMC - PubMed
    1. Radermecker RP, Piérard GE, Scheen AJ. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs. Am J Clin Dermatol. 2007;8(1):21-28. - PubMed
    1. Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231-1255. - PubMed
    1. Strollo F, Guarino G, Armentano V, et al.; On behalf of AMD-OSDI Italian Study Group on Injection Techniques. Unexplained hypoglycaemia and large glycaemic variability: skin lipohypertrophy as a predictive sign. Diabetes Res Open J. 2016;2(1):24-32.
    1. Gupta SS, Gupta KS, Gathe SS, Bamrah P, Gupta SS. Clinical implications of lipohypertrophy among people with type 1 diabetes in India. Diabetes Technol Ther. 2018;20(7):483-491. - PubMed

MeSH terms